Good intentions but these guys still have no idea how to present their story. Big picture, within a 10 year timeframe they should be at 500kozpa from a 10Moz resource. This would give them a $5-10Bn Mkt cap depending on gold price, ie $1-2/share. I think this is why they pulled the trigger on the equity raise. Funding the extra drilling and development would have been too slow. My guess is that it has given them a year head start.
- Forums
- ASX - By Stock
- PNR
- Ann: Norseman Project Growth Plan Presentation
Ann: Norseman Project Growth Plan Presentation, page-5
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNR (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.2¢ |
Change
-0.003(3.16%) |
Mkt cap ! $587.3M |
Open | High | Low | Value | Volume |
9.4¢ | 9.4¢ | 8.7¢ | $1.285M | 14.33M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
33 | 927290 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 292134 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 932294 | 0.092 |
2 | 204611 | 0.091 |
4 | 190060 | 0.090 |
2 | 160000 | 0.089 |
4 | 287000 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 292134 | 10 |
0.094 | 1013452 | 5 |
0.095 | 295884 | 5 |
0.096 | 17000 | 1 |
0.097 | 561682 | 5 |
Last trade - 14.59pm 15/07/2024 (20 minute delay) ? |
Featured News
PNR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online